Generalized anxiety disorder treatment algorithm

Psychiatric Annals

Volumn 26, Issue 4, 1996, Pages 227-232

  Thompson, Peter M ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030490499     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19960401-13     Document Type: Article

References (46)

1. Shader RI, Greenblatt DJ. The pharmacotherapy of acute anxiety. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology. New York, NY: Raven Press; 1995:1341-1348.
2. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. Di Nardo PA, Moras K, Barlow DH, Rapee RM, Brown TA. Reliability of DSM-III anxiety disorder categories. Arch Gen Psychiatry. 1993; 50:251-256.
4. Brown TA, Barlow DH, Liebowitz MR. The empirical basis of generalized anxiety disorder. Am J Psychiatry. 1994; 151:1272-1280.
5. Wise MG, Griffies WS. A combined treatment approach to anxiety in the medically ill. J Clin Psychiatry. 1995; 95:14-19.
6. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994; 51:8-19.
7. Allgulander C, Lavori PW. Excess mortality among 3302 patients with 'pure' anxiety neurosis. Arch Gen Psychiatry. 1991; 48:599-602.
8. Croft-Jeffreys C, Wilkinson G. Costs of neurotic disorder in UK general practice. Psychol Med. 1989; 19:549-558.
9. Reich J. The epidemiology of anxiety. J Nerv Ment Dis. 1986; 174:129-136.
10. Angst J, Vollrath M. The natural history of anxiety disorders. Acta Psychiatr Scand. 1991; 84:446-452.
11. Kellner R, Uhenhuth EH. The rating and self rating of anxiety. Br J Psychiatry. 1991; 159:12-22.
12. Hamilton MC. Diagnosis and rating of anxiety. Br J Psychiatry. 1969; 3:76-79.
13. Borkovec TD, Costello E. Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol. 1993; 61:611-619.
14. Barlow DH, Rapee M, Brown TA. Behavioral treatment of generalized anxiety disorder. Behavior Therapy. 1992; 23:551-570.
15. Durham RC, Allan T. Psychological treatment of generalized anxiety disorder. Br J Psychiatry. 1993; 163:19-26.
16. Luborsky L. Principles of Psychoanalytic Psychotherapy. New York, NY: Basic Books, Inc; 1984.
17. Hollister LE, Muller-Oerlinghausen B, Rickels K, Shader RL. Clinical uses of benzodiazepines. J Clin Psychiatry. 1993; 13:1-147.
18. Rickels K, Schweizer E, Csanalosi I, Case WG, Chung H. Long-term treatment of anxiety and risk of withdrawal. Arch Gen Psychiatry. 1988; 45:444-450.
19. Rickels K. Buspirone in clinical practice. J Clin Psychiatry. 1990; 51:51-54.
20. Napoliello MJ, Domantay AG. Buspirone: a worldwide update. Br J Psychiatry. 1991; 159:40-44.
21. Enkelmann R. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology. 1991; 105:428-432.
22. Feigner JP, Boyer WF. Serotonin IA anxiolytics: an overview. Psychopathology. 1989; 22:21-26.
23. Schweizer E, Rickels K, Lucki I. Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. N Engl J Med. 1986; 313:719-720.
24. Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the national comorbidity survey. Arch Gen Psychiatry. 1994; 51:355-364.
25. Rickels K, Downing R, Schweizer E, Hassman H. Antidepressants for the treatment of generalized anxiety disorder. Arch Gen Psychiatry. 1993; 50:884-895.
26. Kahn RJ, McNair DM, Frankenthaler LM. Tricyclic treatment of generalized anxiety disorder. J Affect Disord. 1987; 13:145-151.
27. Laws D, Asford JJ, Antee JA. A multicenter double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice. Acta Psychiatr Scand. 1990; 81:185-189.
28. Hoehn-Saric R, McLeod DR, Zimmerli WD. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatry. 1988; 49:293-301.
29. Hollander E, Cohen LJ. The assessment and treatment of refractory anxiety. J Clin Psychiatry. 1994; 55:27-31.
30. Lecrubier Y, Puech AT, Azcona A, Bailey PE, Letaste X. A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology. 1993; 112:129-133.
31. 2) mediation of anxiety-therapeutic effects of serazepine in generalized anxiety disorder. Biol Psychiatry. 1993; 34: 41-44.
32. Cutler NR, Sramek JJ, Keppel Hesselink JM, et al. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial. J Clin Psychopharmacol. 1993; 13:429-437.
33. Ansseau M, Olie JP, von Frenckell R, Jourdain G, Stehle B, Guillet P. Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder. Psychopharmacology. 1991; 104:439-443.
34. Ballenger JC, McDonald S, Noyes R, et al. The first double-blind, placebo controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder. Psychopharmacol Bull. 1991; 2:171-179.
35. Schweizer W, Rickels K, Uhlenhuth EH. Issues in the long-term treatment of anxiety disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology. New York, NY: Raven Press; 1995:1349-1360.
36. Miller NS. Liability and efficacy from long-term use of benzodiazepines: documentation and interpretation. Psychiatric Annals. 1995; 25:166-173.
37. Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. N Engl J Med. 1993; 328:1398-1405.
38. Bradwejn J. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions. Can J Psychiatry. 1993; 38:109-113.
39. Roache JD, Meisch RA. Findings from self-administration research on the addiction potential of benzodiazepines. Psychiatric Annals. 1995; 25:153-157.
40. Weddington WW, Brown BS, Haertzen CA, et al. Changes in mood, craving, and sleep during short abstinence reported by male cocaine addicts. Arch Gen Psychiatry. 1990; 47:861-868.
41. Nunes EV, McGrath PJ, Quitkin FM. Treating anxiety in patients with alcoholism. J Clin Psychiatry. 1995; 56:3-9.
42. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry. 1994; 151:1723-1734.
43. Sellers EM, Ciraulo DA, DuPont L, et al. Alprazolam and benzodiazepine dependence. J Clin Psychiatry. 1993; 54:64-74.
44. Kranzler HR, Burleson JA, Del Boca F, et al. Buspirone treatment of anxious alcoholics. Arch Gen Psychiatry. 1994; 51:720-731.
45. Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry. 1994; 151:640-649.
46. Weiss KJ. Management of anxiety and depression syndromes in the elderly. J Clin Psychiatry. 1994; 55:5-12.